Roche Receives CE Mark for Mass Spectrometry Antibiotics Monitoring
The approval expands the company's automated mass spectrometry menu to 39 tests.
The approval expands the company's automated mass spectrometry menu to 39 tests.
The 96-well microplate provides effective removal of phospholipids and proteins while maintaining maximum recovery of target analytes.
The in vitro diagnostic kit is intended for the semiquantitative measurement and evaluation of acylcarnitine, amino acid, free carnitine lysophospholipid, nucleoside, and succinylacetone concentrations.
Without requiring blood culture, the T2Bacteria panel enables rapid, sensitive detection of six clinically relevant sepsis-causing bacteria.
Read MoreThe reconfigured membrane chromatography capsules aim to more effectively recover large molecular weight proteins, such as blood factors and conjugated proteins.
Read MoreMatrix-assisted laser desorption/ionization–time-of-flight mass spectrometry has already brought about a revolution in the microbial identification of bacteria, yeast, and mycelia fungi, but it’s only just beginning.
Read MoreSince the Bruker MALDI Biotyper first came on the market in 2007, more than 1,000 microbiology labs worldwide have acquired the system. This robust MS instrument and procedure offers the benefits of results in less than five minutes, throughput of approximately 200 samples per hour, and low cost per test.
Read MoreDiagnostics giant bioMérieux had more than one reason to celebrate last year. Not only did the company mark its 50th anniversary, it also gained first-to-clinical-market advantage with the launch of its new diagnostic platform, dubbed Vitek MS.
Read MoreThe LCMS-2020 single quadrupole liquid chromatograph mass spectrometer from Shimadzu Corp increases the speed and reliability of HPLC/UHPLC analysis, improving lab productivity.
Read MoreThe Isolute PLD+ protein and phospholipid removal plates from Biotage, Charlotte, NC, provide sample clean-up for blood-based matrix samples for LC-MS/MS analysis.
Read MoreImproving the transfusion service’s ability to provide antigen-matched RBC units for alloimmunized patients.
Read MoreThe technology reduces microbial ID from days to minutes.
Read MoreThe platform performs superior quantitation and exact mass identification for complex sample analysis.
Read MoreTools to help manage testing volume quickly, efficiently, and cost-effectively are in demand.
Read MoreThe new collaboration furthers the companies’ ongoing relationship concerning use of Bruker’s state-of-the-art MALDI-TOF instruments with VeriStrat and other clinical diagnostics in development.
Read MoreFinalizes lease to build 200,000 square foot lab of the future in Marlborough, Mass.
Read MoreQuest Diagnostics signed a definitive agreement today to purchase the clinical outreach laboratory business of UMass Memorial Medical Center, a member of UMass Memorial Health Care.
Read MoreIts future expected impact will be more effective treatment, faster recovery, and lower cost of treatment due to a targeted therapy
Read More